{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:05:46Z","timestamp":1789236346491,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008719","name":"Movember Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008719","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.urolonc.2023.05.011","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:30:07Z","timestamp":1685406607000},"page":"324.e13-324.e20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5038-5859","authenticated-orcid":false,"given":"Michael E","family":"O' Callaghan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Grummet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gilbourd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Frydenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2023.05.011_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0002","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","author":"Ferlay","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0003","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s00345-020-03112-3","article-title":"Infectious complications of prostate biopsy: winning battles but not war","volume":"38","author":"Derin","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0004","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bju.12536","article-title":"Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?","volume":"114","author":"Grummet","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0005","series-title":"EAU \u2013 ESTRO \u2013 ESUR \u2013 SIOG guidelines on prostate cancer","author":"Mottet","year":"2020"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eururo.2020.10.019","article-title":"European Association of Urology position paper on the prevention of infectious complications following prostate biopsy","volume":"79","author":"Pilatz","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0007","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41391-020-0204-8","article-title":"\"TREXIT 2020\": why the time to abandon transrectal prostate biopsy starts now","volume":"23","author":"Grummet","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0008","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41391-020-0263-x","article-title":"Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution","volume":"24","author":"Roberts","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0009","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bju.15039","article-title":"Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study","author":"Berry","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0010","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1017\/S0950268815002885","article-title":"The global burden of major infectious complications following prostate biopsy","volume":"144","author":"Bennett","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0011","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/bju.15062","article-title":"The clinical and financial implications of a decade of prostate biopsies in the NHS: analysis of Hospital Episode Statistics (HES) data 2008-2019","author":"Tamhankar","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0013","unstructured":"Statistics ABo. SEIFA 2016 Technical Paper. 2016:"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0014","series-title":"Cancer in Australia 2019","year":"2019"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0015","doi-asserted-by":"crossref","unstructured":"Halpern JA, Sedrakyan A, Dinerman B, Hsu W-C, Mao J, Hu JC. Indications, utilization and complications following prostate biopsy: New York State analysis. J Urol. 2017: 197:1020-5","DOI":"10.1016\/j.juro.2016.11.081"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0018","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5694\/mja2.50794","article-title":"Differences in treatment choices for localised prostate cancer diagnosed in private and public health services","volume":"213","author":"Te Marvelde","year":"2020","journal-title":"Med J Aust"},{"issue":"Suppl 1","key":"10.1016\/j.urolonc.2023.05.011_bib0019","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/bju.14773","article-title":"A contemporary, nationwide analysis of surgery and radiotherapy treatment for prostate cancer","volume":"124","author":"Roberts","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fonc.2019.00238","article-title":"Geographical variations in prostate cancer outcomes: a systematic review of international evidence","volume":"9","author":"Dasgupta","year":"2019","journal-title":"Fron Oncol"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0022","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.21037\/tau.2019.12.40","article-title":"Transperineal prostate biopsy: a review of technique","volume":"9","author":"Thomson","year":"2020","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0025","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhin.2020.08.020","article-title":"Highly effective prophylaxis with ertapenem for transrectal ultrasound-guided prostate biopsy: effects on overall antibiotic use and inpatient hospital exposure","volume":"106","author":"Bloomfield","year":"2020","journal-title":"J Hosp Infect"},{"issue":"Suppl 3","key":"10.1016\/j.urolonc.2023.05.011_bib0026","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/bju.13165","article-title":"Is transperineal prostate biopsy more accurate than transrectal biopsy in determining final Gleason score and clinical risk category? A comparative analysis","volume":"116","author":"Scott","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0027","series-title":"Prostate cancer in Australian and New Zealand men: Patterns of care within PCOR-ANZ 2015\u20132018","author":"Papa","year":"2021"},{"key":"10.1016\/j.urolonc.2023.05.011_bib0028","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00345-019-02774-y","article-title":"Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospital","volume":"38","author":"Donato","year":"2020","journal-title":"World J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923001862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923001862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:27:39Z","timestamp":1761042459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143923001862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1078143923001862"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.05.011","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}